[Correction by dihydroergotamine of arterial pressure disorders induced by psychiatric chemotherapy].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000009:adverse effects; D000654:Amobarbital / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects*; D001463:Barbiturates / Q000009:adverse effects*; D002090:Butyrophenones / Q000009:adverse effects; D002746:Chlorpromazine / Q000009:adverse effects; D004878:Ergotamine / Q000627:therapeutic use*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000188:drug therapy; D007099:Imipramine / Q000009:adverse effects; D008728:Methotrimeprazine / Q000009:adverse effects; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy; D010424:Pentobarbital / Q000009:adverse effects; D011618:Psychotic Disorders / Q000188:drug therapy; D012631:Secobarbital / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects*
D000928:Antidepressive Agents; D001463:Barbiturates; D002090:Butyrophenones; D014149:Tranquilizing Agents; D000639:Amitriptyline; D012631:Secobarbital; D008728:Methotrimeprazine; D000654:Amobarbital; D010424:Pentobarbital; D007099:Imipramine; D004878:Ergotamine; D002746:Chlorpromazine
Correction par la dihydroergotamine des troubles de la tension artérielle induits par la chimiothérapie psychiatrique.